Mingwei Chen
Impact in
-
- Cancer-related molecular mechanisms research
-
- Lung Cancer Research Studies
Papers in
- Oncology 17
- Lung Cancer Research Studies 3
- Co-authors
- Puyu ShiSuresh S. RamalingamShi‐Yong SunYang TianAsmitananda ThakurPing YueTaofeek K. OwonikokoTianjun Chen
- Journals
- Cancer Letters (2 papers)RSC Advances (2 papers)Cancer Medicine (2 papers)Tumor Biology (2 papers)Anti-Cancer Agents in Medicinal Chemistry (2 papers)
- Partner nations
- ChinaUnited StatesNepal
In The Last Decade
Mingwei Chen
38 papers receiving 655 citations
Peers
Comparison fields: 5 of 87
- Cancer Research 122
- Oncology 219
- Pulmonary and Respiratory Medicine 228
- Molecular Biology 404
- Pathology and Forensic Medicine 65
Countries citing papers authored by Mingwei Chen
This map shows the geographic impact of Mingwei Chen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mingwei Chen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mingwei Chen more than expected).
Fields of papers citing papers by Mingwei Chen
This network shows the impact of papers produced by Mingwei Chen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mingwei Chen. The network helps show where Mingwei Chen may publish in the future.
Co-authors
The 25 scholars most cited alongside Mingwei Chen, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 1 | |
| 2 | 2025 | 0 | |
| 3 | 2025 | 2 | |
| 4 | 2024 | 2 | |
| 5 | 2023 | 0 | |
| 6 | 2023 | 18 | |
| 7 | 2022 | 11 | |
| 8 | 2021 | 3 | |
| 9 | 2021 | 7 | |
| 10 | 2021 | 4 | |
| 11 | 2020 | 1 | |
| 12 | 2020 | 30 | |
| 13 | 2019 | 33 | |
| 14 | 2017 | 13 | |
| 15 | 2017 | 3 | |
| 16 | 2016 | 147 | |
| 17 | 2016 | 12 | |
| 18 | 2015 | 35 | |
| 19 | 2012 | 23 | |
| 20 | 2012 | 46 |
About Mingwei Chen
Mingwei Chen is a scholar working on Oncology, Cancer Research, Molecular Biology, Immunology and Parasitology, having authored 41 papers that have together received 658 indexed citations. Recurring topics across this work include Glycosylation and Glycoproteins Research (6 papers), Lung Cancer Treatments and Mutations (5 papers), PI3K/AKT/mTOR signaling in cancer (4 papers), RNA modifications and cancer (4 papers), Cell death mechanisms and regulation (3 papers), Angiogenesis and VEGF in Cancer (3 papers), Cancer Mechanisms and Therapy (3 papers) and Lung Cancer Research Studies (3 papers). The work is most often cited by research in Cancer Research (122 citations), Oncology (219 citations), Pulmonary and Respiratory Medicine (228 citations), Molecular Biology (404 citations) and Pathology and Forensic Medicine (65 citations). Mingwei Chen has collaborated with scholars based in China, United States and Nepal. Frequent co-authors include Puyu Shi, Suresh S. Ramalingam, Shi‐Yong Sun, Yang Tian, Asmitananda Thakur, Ping Yue, Taofeek K. Owonikoko, Tianjun Chen, Hui Ren and Yiqian Liang. Their work appears in journals such as Cancer Letters, RSC Advances, Cancer Medicine, Tumor Biology and Anti-Cancer Agents in Medicinal Chemistry.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.